Publications by authors named "Claudio Puoti"

Claim this Profile
C
COVID: How to explain differences in lethality between different populations?
Claudio Puoti

Med Hypotheses· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver steatosis: The new epidemic of the Third Millennium. Benign liver state or silent killer?
Claudio Puoti, Maria Giuseppa Elmo, Daniela Ceccarelli, Michela Ditrinco

Eur J Intern Med· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence of hepatocellular carcinoma 13 years after successful antiviral treatment for HCV infection.
Claudio Puoti, Gaetano Lanzetta, Emilio Scotti

J Gastrointestin Liver Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver disease progression in hepatitis C virus carriers with normal alanine aminotransferase levels.
Claudio Puoti, Lia Bellis, Olga Mitidieri Costanza, Maria Giuseppa Elmo

Hepatology· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis.
Claudia Matteucci, Roberta Sorrentino, Lia Bellis, Giuseppe Maria Ettorre, Valentina Svicher, Claudio Puoti

Hepatol Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laparoscopic liver resections in normal and cirrhotic livers: a retrospective analysis in a tertiary hepato-biliary unit.
Giuseppe Maria Ettorre, Andrea Laurenzi, Raffaella Lionetti, Roberto Santoro, Pasquale Lepiane, Claudio Puoti

Dig Liver Dis· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to manage HBeAg-negative chronic HBV infection with normal alanine aminotransferase levels in clinical practice?
Claudio Puoti

Eur J Intern Med· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b.
Adriano M Pellicelli, Mario Romano, Tommaso Stroffolini, Ettore Mazzoni, Fabrizio Mecenate, Claudio Puoti

BMC Gastroenterol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study.
Basilio Fimiani, Domenico Della Guardia, Claudio Puoti, Giuseppe D'Adamo, Olimpia Cioffi

Eur J Intern Med· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet activation and vascular endothelial growth factor 165 release in hepatocellular cancer.
Patrizia Ferroni, Antonella Spila, Roberta D'Alessandro, Francesca Martini, Francesca Iacovone, Claudio Puoti

Clin Chim Acta· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
Ulrich Thalheimer, Lia Bellis, Claudio Puoti, Andrew K Burroughs

Eur J Intern Med· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma cytokines and portopulmonary hypertension in patients with cirrhosis waiting for orthotopic liver transplantation.
Adriano M Pellicelli, Giuseppe Barbaro, Claudio Puoti, Paolo Guarascio, Elena Angela Lusi

Angiology· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term follow-up of radioembolization with yttrium-90 microspheres before liver transplantation: new perspectives in advanced hepatocellular carcinoma.
Giuseppe Maria Ettorre, Roberto Santoro, Claudio Puoti, Rosa Sciuto, Livio Carpanese

Transplantation· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal serum tumour markers values do not imply the presence of extra-hepatic malignancies in patients with chronic liver disease.
Claudio Puoti, Lia Bellis, Riccardo Guarisco

Dig Liver Dis· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV carriers with normal alanine aminotransferase levels: healthy persons or severely ill patients? Dealing with an everyday clinical problem.
Claudio Puoti, Lia Bellis, Riccardo Guarisco, Orlando Dell' Unto, Lucia Spilabotti

Eur J Intern Med· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitation of tissue polypeptide antigen (TPA) in hepatic and systemic circulation in patients with chronic liver diseases.
Claudio Puoti, Lia Bellis, Riccardo Guarisco, Olga Mitidieri Costanza, Renata Felici

J Gastroenterol Hepatol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study.
Claudio Puoti, Adriano M Pellicelli, Mario Romano, Fabrizio Mecenate, Riccardo Guarisco

Liver Int· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, management, and treatment of hepatitis C.
Claudio Puoti, Riccardo Guarisco, Lia Bellis, Lucia Spilabotti

Hepatology· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral treatment of HCV carriers with persistently normal ALT levels.
Claudio Puoti, Lia Bellis, Alessandra Galossi, Riccardo Guarisco, Sabino Nicodemo

Mini Rev Med Chem· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin.
Eric Snoeck, Stephanos J Hadziyannis, Claudio Puoti, Mark G Swain, Thomas Berg

Liver Int· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C virus with normal transaminase levels.
Claudio Puoti

Dig Dis· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma.
Guido Rasi, Annalucia Serafino, Lia Bellis, Maria Teresa Lonardo, Federica Andreola, Claudio Puoti

World J Gastroenterol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis.
Lia Bellis, Sabino Nicodemo, Alessandra Galossi, Riccardo Guarisco, Lucia Spilabotti, Claudio Puoti

J Gastrointestin Liver Dis· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral treatment of HCV-related chronic hepatitis: is the cup half empty, or half full?
Claudio Puoti

J Gastrointestin Liver Dis· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extrahepatic manifestations of chronic HCV infection.
Alessandra Galossi, Riccardo Guarisco, Lia Bellis, Claudio Puoti

J Gastrointestin Liver Dis· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis